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Abstract: The lipids from gonads and polyhydroxynaphthoquinone pigments from body walls of
sea urchins are intensively studied. However, little is known about the body wall (BW) lipids.
Ethanol extract (55 ◦C) contained about equal amounts of saturated (SaFA) and monounsaturated
fatty acids (MUFA) representing 60% of total fatty acids, with myristic, palmitic and eicosenoic acids
as major SaFAs and MUFAs, respectively. Non-methylene-interrupted dienes (13%) were composed of
eicosadienoic and docosadienoic acids. Long-chain polyunsaturated fatty acids (LC-PUFA) included
two main components, n6 arachidonic and n3 eicosapentaenoic acids, even with equal concentrations
(15 µg/mg) and a balanced n6/n3 PUFA ratio (0.86). The UPLC-ELSD analysis showed that a great
majority of the lipids (80%) in the ethanolic extract were phosphatidylcholine (60 µg/mg) and
phosphatidylethanolamine (40 µg/mg), while the proportion of neutral lipids remained lower
than 20%. In addition, alkoxyglycerol derivatives—chimyl, selachyl, and batyl alcohols—were
quantified. We have assumed that the mechanism of action of body wall lipids in the present study is
via the inhibition of MAPK p38, COX-1, and COX-2. Our findings open the prospective to utilize this
lipid fraction as a source for the development of drugs with anti-inflammatory activity.
Keywords: sea urchin; body wall lipids; inhibition of p38 MAPK; COX; GC-MS; UPLC-ELSD
1. Introduction
Sea urchins have wide distribution and they play an important role in ecosystem of both
shallow and deeper waters of the ocean. A number of species of sea urchin are intensively utilized
in food, pharmaceutical, and cosmetic industries. In 2015, the total world production of edible
sea urchin was 71,229 tons [1]. Green sea urchin, Strongylocentrotus droebachiensis, is an edible
species of the phylum Echinodermata, which is a typical inhabitant of the polar region of Russia,
including the Barents Sea. The gonads are delicacies in many parts of the world and considered as
highly valued seafood. Several studies have indicated that the gonads of S. droebachiensis are rich in
important bioactive compounds like polyunsaturated fatty acids (PUFA), phospholipids, tocopherols,
sterols [2–4], carotenoids [2,5], and amino acids [6,7]. Extract of gonad tissue has also revealed effective
anti-inflammatory and antidiabetic properties [4].
After removal of gonads, the residual shells and spines (body wall, BW) of sea urchins which
account for more than 40% of total body weight are discarded as waste. Previous studies have also
shown that sea urchin BW contain polyhydroxynaphthoquinones. These pigments have evoked
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renewed interest as a promising source for the development of drugs. A number of bioactivities have
been found, for example antiallergic [8], antidiabetic [9], antihypertensive [10], anti-inflammatory [11],
antioxidant [12–14], cardioprotective [15], and hypocholesterolemic [16] effects.
Total concentration of pigments in sea urchin body wall is quite low (1.2–1.6 mg/g) [17], however,
a purification method has been recently reported in order to improve the yield of shell pigments [18].
The inner layer of the body wall, on the contrary, is covered with a biomembrane, consisting of lipids.
However, their profile has not been described yet. Marine lipids are unique sources of essential fatty
acids, phospholipids, sterols, and alkoxyglycerols, and they have a broad pharmacological activity.
The aim of this study was to analyze the ethanolic extract of lipids underlying the body wall (BW)
of green sea urchin by using gas chromatography-mass spectrometry (GC-MS) and ultra-performance
liquid chromatography (UPLC-ELSD). In addition, the anti-inflammatory potential of BW lipids was
investigated in vitro.
2. Results
2.1. Fatty Acid Composition of Body Wall (BW) Lipids
The ethanolic (95%) extract, which was prepared at 55 ◦C for 3 h, contained about equal amounts of
saturated (SaFA) and monounsaturated fatty acids (MUFA) representing 60% of total fatty acids. Myristic,
palmitic, and eicosenoic acids were the main SaFAs and MUFAs, respectively (Table 1 and Figure 1).
The principal MUFA is unusual and this isomer is suggested to be 20:1n15. Among non-methylene-interrupted
dienes (NMID, 13%), eicosadienoic (20:2) and docosadienoic (22:2) acids were characteristic. They are typical
constituents of sea urchin among which 20:2∆5,11 often appears as the most abundant isomer. In addition,
n12 and n5 isomers of 18:1, 20:3n9 and cyclopropaneoctanoic and -decanoic acid 2-octyl methyl esters
accounted 10 µg/mg.
The composition of long-chain polyunsaturated fatty acids (LC-PUFA) was characterized by
two major components, n6 arachidonic (20:4n6; AA) and n3 eicosapentaenoic acids (20:5n3; EPA),
with equal concentrations (15 µg/mg) and a balanced n6/n3 PUFA ratio (0.86). These LC-PUFAs
possess important properties, since they act as the precursors of eicosanoids.
A very low amount of docosahexaenoic acid (22:6n3, DHA) was typical for BW lipid extract
(Table 1), as well as the high proportion of free (22%) vs. esterified fatty acids. Quantitatively, free AA
covered 1/3 of total AA and free EPA 1/4 of total EPA, respectively, reflecting decomposition of bound
fatty acids during extraction procedure. The relatively high proportion of LC-PUFAs, n6 AA, and n3
EPA (20%), would suggest that the extract is rich in phospholipids.
Table 1. The concentrations (µg/mg; mean ± SD, n = 3) and relative amounts (%) of bound and free
fatty acids in ethanolic extract of BW lipids of sea urchin determined by GC-MS.
Fatty Acids Bound Fatty Acids as FAME % FFA %
C10:0–C13:0 0.4 ± 0.1 0.3 - -
C14:0 15.1 ± 0.7 9.6 3.7 ± 0.1 8.4
C15:0 1.5 ± 0.1 0.9 0.5 ± 0.1 1.1
C16:0 21.9 ± 1.2 13.9 5.0 ± 0.2 11.4
C18:0 4.0 ± 0.2 2.5 2.1 ± 0.1 4.8
C19:0 1.0 ± 0.1 0.6 - -
C20:0 0.6 ± 0.1 0.4 - -
Σ SaFAΣ 44.5 ± 2.1 28.2 11.3 ± 0.3 25.7
C14:1n5 1.1 ± 0.1 0.7 - -
C16:1n9 0.9 ± 0.1 0.6 - -
C16:1n7 7.8 ± 0.6 4.9 1.9 ± 0.1 4.3
C16:1n5 4.5 ± 0.2 2.8 - -
C18:1n9 3.0 ± 0.2 1.9 1.4 ± 0.1 3.2
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Table 1. Cont.
Fatty Acids Bound Fatty Acids as FAME % FFA %
C18:1n7 4.2 ± 0.2 2.7 2.9 ± 0.1 6.6
C20:1n15 16.7 ± 0.8 10.6 - -
C20:1n9 5.2 ± 0.3 3.3 8.2 ± 0.4 18.6
C20:1n7 1.3 ± 0.1 0.8 - -
C22:1n9 4.3 ± 0.2 2.7 - -
Σ MUFA 49.0 ± 1.3 31.0 14.4 ± 0.4 32.7
20:2∆5,11 12.2 ±1.2 7.7 - -
20:2∆5,13 3.0 ± 0.5 1.9 - -
22:2∆7,13 0.9 ± 0.2 0.6 - -
22:2∆7,15 4.7 ± 0.4 3.0 - -
Σ NMID 20.9 ± 1.9 13.2 - -
C18:2n6 1.5 ± 0.1 0.9 5.2 ± 0.2 11.8
C20:2n6 1.9 ± 0.1 1.2 - -
C20:3n6 0.9 ± 0.1 0.6 - -
C20:4n6 15.8 ± 0.6 10.0 7.3 ± 0.1 16.6
Σ n6 PUFA 20.1 ± 1.0 12.7 12.5 ± 0.8 28.4
C18:3n3 1.2 ± 0.1 0.8 - -
C18:4n3 2.3 ± 0.1 1.5 - -
C20:3n3 2.3 ± 0.2 1.5 - -
C20:4n3 0.6 ± 0.1 0.4 - -
C20:5n3 15.2 ± 0.7 9.6 5.8 ± 1.0 13.2
C22:5n3 0.2 ± 0.1 0.1 - -
C22:6n3 1.7 ± 0.1 1.1 - -
Σ n3 PUFA 23.5 ± 1.1 14.9 5.8 ± 1.0 13.2
Σ Fatty acids 158.0 ± 5.3 100.0 44.0 ± 1.8 100.0
n6/n3 PUFA 0.86 2.16
FAME, fatty acid methyl ester; FFA, free fatty acid; SaFA, saturated fatty acid; MUFA, mono-unsaturated fatty acid;
NMID, non-methylene-interrupted diene; PUFA, polyunsaturated fatty acid.
Figure 1. GC-MS analysis of transesterified and trimethylsilylated (TMS) fatty acids from ethanolic
extract of BW lipids of sea urchin. Total ion (TIC) and extracted ion chromatogram (m/z 205) shows
TMS derivatives of alkylglycerols (AOG; (1) 16:0-AOG, (2) 18:1-AOG, and (3) 18:0-AOG) and sterols
(peaks 4–11, TIC): (4–5) unidentified sterols, (6) cholesterol, (7) desmosterol, (8) cholecalciferol as
shoulder, (9) campesterol, (10) stigmasterol, and (11) clionasterol. Heptadecanoic acid (as FAME and
TMS derivative) was used as internal standard (IS). Other peaks represent FAMEs and TMS ethers.
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2.2. Sterols and Alkoxyglycerols (AOG)
Sterol and AOG samples were analyzed by GC-MS as TMS-derivatives. BW lipid extract contained
mainly cholesterol (50 µg/mg) (Figure 1 and Table 2). Minor non-cholesterol sterols included
desmosterol, campesterol, stigmasterol, and clionasterol (gamma-sitosterol) which is a common
constituent in oyster, for example [19]. For GC-MS analyses from abundant AOG sources, purified
samples from unsaponifiable fraction have been used. Because of low concentration, extracted ion
chromatogram (m/z 205) of silylated AOG was taken to confirm the peak location. This fragment is
formed after cleavage between carbons 1 and 2 of the glycerol moiety [20]. Quantified AOG derivatives
were chimyl (C16:0), selachyl (C18:1) and batyl alcohols (C18:0).
Table 2. Sterol and alkoxyglycerol (AOG) content (µg/mg; mean ± SD, n = 3) of ethanolic extract of
BW lipids of sea urchin. Sterols and AOGs were determined as TMS ethers by GC-MS.
Sterols and AOGs µg/mg
Cholesterol 50.3 ± 2.8
Non-cholesterol sterols * 10.6 ± 0.5
C16:0-AOG 1.0 ± 0.1
C18:1-AOG 0.4 ± 0.1
C18:0-AOG 0.3 ± 0.1
Σ Alkoxyglycerols 1.7 ± 0.2
* Non-cholesterol sterols include desmosterol, campesterol, stigmasterol, clionasterol, and two unidentified sterols
(Figure 1).
2.3. Lipid Classes
The UPLC-ELSD analyses from the ethanol extract of BW lipids, shown in Figure 2 and Table 3,
demonstrate high abundance of phospholipids (PL, 80%), especially those of phosphatidylcholine
(PC, 60 µg/mg) and phosphatidylethanolamine (PE, 40 µg/mg). The proportion of neutral lipids
remained less than 20%. It is clear that ethanol extracts polar PLs better than neutral lipids (NL) like
triacylglycerols and cholesteryl esters. The fatty acid profile with relatively high content of PUFAs
indicates that the fatty acids have mostly originated from PLs. Lysophosphatidylcholine (LPC) eluted
late as a broad peak and covered about 8% of total lipids.
Figure 2. UPLC-ELSD chromatogram of BW lipids of ethanol (95%) extract of sea urchin. UPLC, ultra-
performance liquid chromatography; ELSD, evaporative light scattering detector; WE, wax ester,
SE, steryl ester; TG, triacylglycerol; Chol, cholesterol; ip, impurity; Cer, ceramide; CL, cardiolipin;
PE, phosphatidylethanolamine; PI, phosphatidylinositol; PS, phosphatidylserine; PC, phosphatidylcholine;
SPH, sphingomyelin; LPC, lysophosphatidylcholine.
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Table 3. Concentration of major lipid classes (µg/mg, mean ± SD; n = 3) and their relative amounts (%)
in ethanolic extract of BW lipids of sea urchin. Analyses were carried out by UPLC-ELSD.
Lipid Classes µg/mg %
WE + SE 14.6 ± 0.7 8.4
TG 15.9 ± 1.0 9.1
Σ Neutral lipids 30.5 ± 1.6 17.5
PE 38.6 ± 1.1 22.2
PI + PS 27.8 ± 0.1 16.0
PC 63.3 ± 1.7 36.4
LPC 13.5 ± 0.5 7.8
Σ Phospholipids 143.2 ± 0.7 82.5
Σ Total lipids 173.7 ± 2.3 100.0
WE, wax ester; SE, steryl ester; TG, triacylglycerol; PE, phosphatidylethanolamine; PS, phosphatidylserine;
PI, phosphatidylinositol; PC, phosphatidylcholine; LPC, lysophosphatidylcholine.
2.4. Bioactivity of Body Wall (BW) Lipids
Inflammation is a part of the body’s normal response to infection and injury, extreme or
inappropriate inflammation, on the contrary, is linked to the pathobiology of several diseases [21].
The anti-inflammatory effect of S. droebachiensis lipids of the extract was assessed in the human
mononuclear U937 cells stimulated with lipopolysaccharide (LPS). The stimulation of U937 resulted
in direct activation of MAPK p38. The results (Table 4) revealed that BW lipids dose-dependently
inhibited MAPK p38. The most effective dose of the lipid extract was 0.033 µg/mL. In addition,
BW lipids were clearly more potent than a specific MAPK p38 inhibitor SB203580 (1.88 µg/mL) at
the doses of 0.0037–0.1 µg/mL. The COX-1 and COX-2 isoenzymes were inhibited by BW lipids
dose-dependently with IC50 = 15.7 µg/mL and 21 µg/mL, respectively.
Table 4. Effect of body wall (BW) lipids on the phosphorylation of MAPK p38 in the human mononuclear
U937 cells Mean ± SEM, (n = 6).
Sample, Concentration Percentage of MAPK p38 (%)
Intact cells (no stimulation with LPS) 23.0 ± 1.2
Control cells stimulated with LPS (1 µg/mL) 100
SB203580 (1.88 µg/mL) + LPS 30.0 ± 1.7
BWL (10 µg/mL) + LPS 59.0 ± 1.3
BWL (5 µg/mL) + LPS 53.0 ± 1.9
BWL (1 µg/mL) + LPS 49.0 ± 0.9
BWL (0.5 µg/mL) + LPS 38.0 ± 1.6
BWL (0.1 µg/mL) + LPS 17.0 ± 1.5
BWL (0.033 µg/mL) + LPS 12.0 ± 0.5
BWL (0.011 µg/mL) + LPS 21.0 ± 1.7
BWL (0.0037µg/mL) + LPS 27.0 ± 0.7
BWL (0.0012 µg/mL) + LPS 38.0 ± 1.6
BWL (0.0004 µg/mL) + LPS 52.0 ± 1.2
3. Discussion
The fatty acid composition of the ethanol extract of body wall (BW) lipids of sea urchin
(Table 1 and Figure 1) was consistent with literature including non-methylene interrupted dienes
(NMID) and unusual cyclopropane derivatives [2,22,23]. The principal PUFAs were n6 arachidonic
(AA) and n3 eicosapentaenoic acids (EPA). The proportion docosahexanoic acid (22:6n3, DHA) in BW
lipids, on the contrary, was very low as has been reported also by others [2,22]. In our previous study,
gonads of sea urchin contained about 50 µg/mg of EPA and DHA [4]. Analysis of lipid classes showed
two major phospholipids—i.e., phosphatidylcholine and phosphatidylethanolamine. This data is in
general agreement with the phospholipids profile of gonads of S. droebachiensis [7].
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Fats in human diet are responsible for severe health problems because of long-term intake of
unbalanced proportions of SaFA, MUFA, n6, and n3 PUFA. The n6 and n3 PUFA intake favors too much
n6 PUFA. This presupposes an adequate intake of PUFA precursors (n6 linoleic and n3 alpha-linolenic
acids) to form long-chain LC-PUFAs (n6-AA and n3-EPA), which, in turn, act as eicosanoid precursors
which determine the balance and effects of eicosanoids in the body [24]. Arachidonic acid is converted
to thromboxane-type eicosanoids via cyclo-oxygenase enzyme, while EPA is converted to prostacycline,
antagonizing the conversion of AA to eicosanoids. This would enhance anti-aggregatory and
anti-inflammatory conditions [25].
From a biological point of view, the biomembrane covering the inner layer of the body wall
plays an important protective role for survival of the sea urchin. Damage of the body wall will
follow with inflammation. Mitogen-activated protein kinases (MAPKs) are among the most important
molecules in the signaling pathways among which MAPK p38 signaling plays an essential role
in regulating cellular processes, especially inflammation [26]. In our study, we observed 88% of
MAPK p38 inhibition by body wall (BW) lipids at a very low dose of 0.033 µg/mL (Table 4).
The inhibition of MAPK p38 might be attributed to the different active compounds of BW lipids.
Ait-Said et al. [27] established that EPA, unlike DHA, failed to inhibit nuclear factor-κB (NF-κB)
activation, and suppressed MAPK p38 phosphorylation in IL-1β stimulated human pulmonary
microvascular endothelial cells. The anti-inflammatory properties of EPA in LPS-stimulated BV2
microglia cells were mediated by downregulation of NF-κB and MAPKs such as ERK, p38, JNK,
and Akt activation [28].
Cyclooxygenase-2 (COX-2) isoenzyme could be induced by a wide range of proinflammatory
agents. Prostaglandin-dependent amplification of COX-2 is hypothesized to be an important part of
sustained proliferative and chronic inflammatory conditions [29]. EPA as well as DHA effectively
inhibited COX-2 expression in LPS-stimulated HUVEC endothelial cells [30]. Recently, we have
reported that lipid rich fraction from gonads of S. droebachiensis inhibited COX-2 with IC50 = 49 µg/mL,
but was not effective against COX-1 isoform [4]. It is important to note that, in our current study,
body wall lipids were more effective and inhibited COX-2 in lower dose and inhibited COX-1 with
IC50 = 15.7 µg/mL.
Low amounts of ether-bonded alkoxyglycerols were also found in ethanolic extract of BW lipids
(Figure 2 and Table 3). The total amount of AOG was less than 0.2% which would correspond about
the level in human milk and plasma lipids, for example [31]. By using the present UPLC-ELSD
method, however, it was not possible to detect glycerophospholipid-based alkyl- and alkenylacyl
lipids, since their analysis first requires the separation of phospholipid subclasses. These lipids, such
as glycerophosphatidylethanolamine and -choline, are known to have important activities.
Biological activity of alkoxyglycerols has been known already more than half a century. Some of
the activities, such as anti-inflammatory effects and protection against radiation damage, are still
under study together with the more recent interest in the possible cell-signaling properties of
phospholipid-based ether-bonded compounds. These lipids have shown multiple pharmacological
activities such as anti-cancer [32], wound healing [33], and immunostimulatory effects [34]. It has
been demonstrated that AOG differentially modulate LPS-mediated MAPK and NF-κB signaling in
adipocytes and that they do not activate signaling in the absence of LPS. Saturated alkyl chain increased
LPS-mediated activation of the MAPK signaling, which could cause the expression of inflammatory
genes. Conversely, unsaturated alkyl chain decreased LPS-mediated activation of the MAPK and
NF-κB signaling [35].
Taking into account all these aspects, we can hypothesize that the lipids containing n3 PUFA,
especially EPA, could contribute anti-inflammatory activity. Besides the content of neutral lipid
alkoxyglycerols, it is necessary to confirm the occurrence of alkyl- and alkenylacyl lipids and fatty acid
compositions of individual phospholipid classes in BW lipid extracts.
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4. Material and Methods
4.1. Sample Preparation and Extraction of Lipids
Green sea urchins, Strongylocentrotus droebachiensis, were harvested in the Barents Sea in 2016
by divers. After removal of gonads, coelomic fluid, and internal organs, the shells with spines were
washed in cold tap water, dried at 4 ◦C for two days and stored in a dark place. The shells with spines
(20 g) were ground and macerated with 160 mL of 95% ethanol for 3 h with constant stirring at 55 ◦C.
The extract was filtered and evaporated into dryness by rotary evaporator (IKA RV 10; IKA®-Werke
GmbH & Co. KG, Staufen, Germany). The yield of the body wall lipids was 1.2%.
4.2. Chemical Analyses
4.2.1. Analysis of Fatty Acids, Sterols and Alkoxyglycerols by GC-MS
Analyses of bound and free (FFA) fatty acids were carried out by using the method described
previously [4]. Shortly, the lipid extract, spiked with internal standards (IS) TG(17:0/17:0/17:0) and
FFA 17:0, were transesterified with 0.5 N sodium methoxide at 45 ◦C for 5 min. After acidification,
fatty acid methyl esters (FAMEs) as well as FFAs were extracted with petroleum ether. The method
enabled the esterification of bound fatty acids from neutral lipids and also from phospholipids [36].
The mixtures of FAMEs and FFAs were used as reference substances.
The analyses were performed on an Agilent 7890A GC mounted with Gerstel MPS injection
system and an Agilent 5975C mass selective detector. The column was an Agilent FFAP silica capillary
column (25 m × 0.2 mm × 0.3 µm) and helium was used as the carrier gas. The oven temperature
raised from 70 ◦C to 235 ◦C, with a total run time of 30 min. The temperatures of the injector and MS
source were 220 and 230 ◦C, respectively, and the data were collected in EI mode (70 eV) at a mass
range of m/z 40–600.
After analyzing the composition of FAMEs by GC-MS, the same samples were derivatized to
determine the contents of FFAs, cholesterol, and minor sterols. Analyses of alkoxyglycerols (AOG) were
done according to a previous method [31]. Samples were evaporated, re-dissolved in dichloromethane,
and silylated with MSTFA [N-Methyl-N-(trimethylsilyl)-trifluoroacetamide] (Pierce, Rockford, IL, USA)
at 80 ◦C for 20 min. TMS-derivatives were analyzed on an Rtx-5-ms column (15 m × 0.25 mm × 0.25 µm)
(Restek, Bellefonte, PA, USA). The split ratio was 20:1 and the oven temperature was programmed to go
from 70 (1 min) to 270 ◦C at a rate of 10 ◦C/min, the total run time was 30 min. The data was collected
by MSD ChemStation software (Agilent Technologies, Inc., Santa Clara, CA, USA). Identification of
the compounds was based on retention times of reference substances, library comparisons (The Wiley®
Registry of Mass Spectral Data, John Wiley and Sons, Inc., New York, NY, USA; NIST 08 spectral library,
National Institute of Standards and Technology, Gaithersburg, MD, USA) and on literature data.
4.2.2. Analysis of Lipid Classes by UPLC-ELSD
The same lipid extract as above (without derivatization) was analyzed on a Waters AcquityTM
H-class UPLC (ultra-performance liquid chromatograph) equipped with an evaporative light scattering
detector (ELSD) by modifying previous conditions [37]. Separation of the lipid classes was carried
out on a Waters Spherisorb silica column (3 µm, 100 × 2.1 mm I.D.). The gradient solvent system
consisted of (A) iso-octane-tetrahydrofurane (99:1), (B) 2-propanol-dichloromethane (3:2) and (C)
2-propanol-water (1:1) with an analysis time of 20 min. The temperature of the drift tube was 40 ◦C
and air flow 50 psi. The multigradient system started from 100% A, the proportion of A decreased
to 32%, that of B increased to 52% and simultaneously that of C (containing water) increased to
16%. Stable retention times were obtained by keeping continuous cycle running. The flow rate was
0.800 mL/min and the injection volume 2 µL. The temperature of the sample manager was 10 ◦C.
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4.3. Biological Assays
4.3.1. Cell Lines and Cell Culture
The human mononuclear U937 cells were purchased from the Russian Collection of Cell Culture
(Institute of Cytology of Russian Academy of Science, Saint-Petersburg, Russia), and maintained
at 37 ◦C in a humidified 95% air and 5% CO2 in RPMI1640 supplemented with 2 mM glutamine,
10% heat-inactivated FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin. BW lipids were
dissolved in dimethyl sulfoxide (DMSO) as a stock solution at a 10 mg/mL concentration, and the stock
solution was then diluted with the medium to the desired concentration prior to use. Cells derived from
the freeze-down batch were thawed, grown, and seeded (106 cells per well) onto 12-well tissue culture
plates and cultured in medium for 24 h. The cells were then stimulated with 1 µg/mL Escherichia coli
LPS (Sigma-Aldrich, St. Louis, MO, USA) at 37 ◦C for 1 h. After that the cells were treated with
SB203580 (Sigma-Aldrich, St. Louis, MO, USA) and various concentrations of BWL at 37 ◦C for 1 h.
4.3.2. Western Blotting
Cells were washed in cold (4 ◦C) phosphate-buffered saline (PBS; 0.5 mol/L sodium phosphate,
pH 7.5) and separated by centrifugation (Hermle Labortechnik, Germany) at 1500 rpm−1 for 5 min at
4 ◦C, harvested by gentle scraping, and used to prepare total protein or nuclear extracts. Cells were
treated with lysis buffer—1 mol/L Tris-HCl pH 7.5, 1.5 mol/L NaCl, 10% Triton X-100, 0.2 mol/L
Na3VO4, 1 mol/L NaF, 0.2 mol/L EDTA, phenylmethylsulphonyl fluoride (PMSF), Abcam’s protease
inhibitor cocktail, and Abcam’s phosphatase inhibitor cocktail—for 20 min at 4 ◦C. The lysates were
then clarified by centrifugation at 15,000 rpm−1 for 15 min at 4 ◦C and the supernatant was collected.
The protein concentrations of the extracts were determined using the [38] with an XMark
spectrophotometer (Bio-Rad, Hercules, CA, USA). For Western blot analysis, 40 µg of protein
were desaturated by boiling with Laemmli buffer (5 min at 100 ◦C) and subjected to 4–14%
SDS-polyacrylamide gels, and transferred to nitrocellulose membrane membranes (Bio-Rad) by
electroblotting. The membranes were blocked with 5% non-fat dry milk in PBS with Tween 20 buffer
(PBS-T) (Tris-HCl (pH 7.5), 1.5 mol NaCl, and 0.1% Tween 20) for 1 h at room temperature. Membranes
were then incubated overnight at 4 ◦C with the primary antibodies, probed with enzyme-linked
secondary antibodies, and visualized using a chemiluminescent detection with LumiGLO® reagent
(Cell Signaling Technology, Danvers, MA, USA) according to the manufacturer’s instructions.
After detection, the membranes were scanned (Epson Perfection V330 Photo, Seiko Epson Corporation,
Nagano, Japan) and processed with Scion Image software (Alpha 4.0.3.2, Scion, Fredrick, MD, USA).
The band intensities were used for calculations. Phospho-p38 MAPK antibody, rabbit, p38 MAPK XP
rabbit mAb, β-actin rabbit mAb, and anti-rabbit IgG, HRP-linked antibody were from Cell Signaling
Technology (Danvers, MA, USA).
4.3.3. Assessment of Cyclooxygenase Activity
Inhibition of human recombinant cyclooxygenase COX-1 and COX-2 (Cayman Chemical,
Ann Arbor, MI, USA) was assessed according to the manufacturer’s instructions. Indomethacin
(1 µg/mL) from Sigma (St. Louis, MO, USA) was used as reference. The BWL was dissolved in DMSO
prior to analysis.
4.4. Statistical Analysis
Data were analyzed using Statistica version 10.0. All biological assay data are presented as
mean ± SEM or mean ± SD. Differences among groups were evaluated by one way analysis
of variance (ANOVA) and post-hoc Tukey’s test. In all comparisons, p < 0.05 was accepted as
statistically significant.
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5. Conclusions
To the best of our knowledge, this is the first time when the profile of body wall lipids is reported.
It can be assumed that the mechanism of action of body wall lipids in the present study is via the inhibition
of MAPK p38, COX-1, and COX-2. Our findings open the potential to utilize this lipid fraction as a source
for the development of drugs with anti-inflammatory activity. Further- more, the anti-inflammatory
properties of the lipid extract may be useful for ameliorating neuro- degenerative diseases, as well as
suppressing LPS-induced shock.
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